Informações:
Falhas:
ID
15929
Descrição
Glucose and Lipid Metabolism on Antipsychotic Medication; ODM derived from: https://clinicaltrials.gov/show/NCT00515723
Link
https://clinicaltrials.gov/show/NCT00515723
Palavras-chave
Versões (1)
- 19/06/2016 19/06/2016 -
Transferido a
19 de junho de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Schizophrenia NCT00515723
Eligibility Schizophrenia NCT00515723
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00515723
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
age
Item
aged 18-60 years
boolean
C0001779 (UMLS CUI [1])
dsm-iv; haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone treatment
Item
patients: otherwise healthy and meets dsm-iv criteria for schizophrenia or schizoaffective disorder, any type, treated with haloperidol, olanzapine, clozapine, quetiapine, ziprasidone, aripiprazole, or risperidone for at least 3 months
boolean
C0220952 (UMLS CUI [1])
C0018546 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
C0009079 (UMLS CUI [4])
C0123091 (UMLS CUI [5])
C0380393 (UMLS CUI [6])
C0299792 (UMLS CUI [7])
C0073393 (UMLS CUI [8])
C0018546 (UMLS CUI [2])
C0171023 (UMLS CUI [3])
C0009079 (UMLS CUI [4])
C0123091 (UMLS CUI [5])
C0380393 (UMLS CUI [6])
C0299792 (UMLS CUI [7])
C0073393 (UMLS CUI [8])
otherwise healthy
Item
controls: healthy
boolean
C1708335 (UMLS CUI [1])
informed consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
medication changes
Item
no antipsychotic medication changes for 3 months, and no other medication changes for 2 weeks prior to baseline evaluations.
boolean
C0580105 (UMLS CUI [1])
psychiatric disorder, severe
Item
axis i psychiatric disorder criteria met in self except for substance use disorders as below
boolean
C0004936 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
substance abuse
Item
patients and controls: meets dsm-iv criteria for the diagnoses of substance abuse within the past 3 months
boolean
C0038586 (UMLS CUI [1])
involuntary legal status
Item
involuntary legal status (as per missouri law)
boolean
C0580275 (UMLS CUI [1])
concomitant disease
Item
the presence of any serious medical disorder that may confound the assessment of relevant biologic measures or diagnosis, including: significant organ system dysfunction, metabolic diseases, type 1 diabetes mellitus, symptomatic type 2 diabetes mellitus (see below), pregnancy, endocrine disease, coagulopathy, clinically significant anemia, that would preclude blood sampling (as determined by the pi) or acute infection;
boolean
C0243087 (UMLS CUI [1])
atypical antipsychotic medication
Item
patients taking more than one atypical antipsychotic medication;
boolean
C0748066 (UMLS CUI [1,1])
C0205182 (UMLS CUI [1,2])
C0205182 (UMLS CUI [1,2])
prescription medications
Item
subjects taking certain prescription medications (as determined by pi on a case by case basis).
boolean
C3843193 (UMLS CUI [1])